Kinnate Biopharma Inc. (KNTE)
NASDAQ: KNTE · IEX Real-Time Price · USD
4.30
+0.52 (13.76%)
At close:
May 31, 2023, 4:00 PM
4.31
+0.01 (0.23%)
After-hours:
May 31, 2023, 7:28 PM EDT
Kinnate Biopharma Stock Forecast
Stock Price Forecast
According to 4 stock analysts, the average 12-month stock price forecast for KNTE stock stock is $17.35, which predicts an increase of 303.49%. The lowest target is 5.40 and the highest is 26. On average, analysts rate KNTE stock stock as a strong buy.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KNTE stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 2 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 5 | 4 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.96
from -2.64
EPS Next Year
-2.94
from -2.96
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 9.01M | 58.42M | 107.11M |
| Revenue Growth | - | - | - | - | - | - | - | - | 548.08% | 83.35% |
| EPS | -2.09 | -2.72 | -5.28 | -2.06 | -2.64 | -2.96 | -2.94 | -2.82 | -0.88 | - |
| EPS Growth | - | - | - | - | - | - | - | - | - | - |
| No. Analysts | - | - | - | - | - | 10 | 9 | 7 | 4 | 4 |
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | n/a | n/a | 39.2M | 195.4M | 162.5M |
| Avg | n/a | n/a | 9.0M | 58.4M | 107.1M |
| Low | n/a | n/a | n/a | n/a | 54.2M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | 2,067.9%
| 178.1%
|
| Avg | - | - | - | 548.1%
| 83.4%
|
| Low | - | - | - | - | -7.2%
|
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| High | -2.44 | -2.00 | -2.05 | 0.18 |
| Avg | -2.96 | -2.94 | -2.82 | -0.88 |
| Low | -3.61 | -3.53 | -3.68 | -1.86 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.